Abstract
Abnormal angiogenesis is a critical feature of many diseases, including cancers and their precursors. Although the association between prostate carcinogenesis and changes in microvascular architecture is well known, these changes are not well-documented from a quantitative point of view. The present study is a review about stereological estimates of the number of quiescent and proliferative endothelial cells, and length of both blood and lymphatic microvessels in normal and prostate cancer tissues. A decrease of endothelial cell density, together with an increase of microvessel length density, was detected in prostate cancer specimens. When comparing blood and lymphatic microvessels the next findings were remarked: The length density from blood vessels was greater than in lymphatics. The average vascular diameter for lymphatics was decreased in cancer in comparison with controls. The endothelial cells per unit of volume were higher in blood vessels than in lymphatics. The surface density of endothelium and the average of endothelial cell surface, were similar in blood and lymphatic vessels in all the groups irrespective of normal, intratumoral or peritumoral locations. The average vascular diameter was the only parameter that in the lymphatics shows a gradient of decreasing from normal to intratumoral tissues, due to mechanical compression by the growing tumour. In contrast with the angiogenesis observed in prostate cancer, the lymphangiogenesis seems to be not relevant. The relevance of the quantification of the blood and lymph microvessels for evaluating anti-angiogenesis strategies in the therapy of prostate cancer is discussed.
Keywords: Angiogenesis, Cancer, Lymphatics, Microvessels, Prostate, Stereology.
Current Cancer Therapy Reviews
Title:Stereological Quantification of Blood and Lymph Microvessels in Prostate Cancer. Its Relevance for the Anti-angiogenetic Therapy
Volume: 10 Issue: 1
Author(s): Almudena Coloma, Javier Codesal, Ildefonso Ingelmo, Jesus Ruiz, Fernando Teba, Jose M. Pozuelo, Rosario Rodriguez and Luis Santamaria
Affiliation:
Keywords: Angiogenesis, Cancer, Lymphatics, Microvessels, Prostate, Stereology.
Abstract: Abnormal angiogenesis is a critical feature of many diseases, including cancers and their precursors. Although the association between prostate carcinogenesis and changes in microvascular architecture is well known, these changes are not well-documented from a quantitative point of view. The present study is a review about stereological estimates of the number of quiescent and proliferative endothelial cells, and length of both blood and lymphatic microvessels in normal and prostate cancer tissues. A decrease of endothelial cell density, together with an increase of microvessel length density, was detected in prostate cancer specimens. When comparing blood and lymphatic microvessels the next findings were remarked: The length density from blood vessels was greater than in lymphatics. The average vascular diameter for lymphatics was decreased in cancer in comparison with controls. The endothelial cells per unit of volume were higher in blood vessels than in lymphatics. The surface density of endothelium and the average of endothelial cell surface, were similar in blood and lymphatic vessels in all the groups irrespective of normal, intratumoral or peritumoral locations. The average vascular diameter was the only parameter that in the lymphatics shows a gradient of decreasing from normal to intratumoral tissues, due to mechanical compression by the growing tumour. In contrast with the angiogenesis observed in prostate cancer, the lymphangiogenesis seems to be not relevant. The relevance of the quantification of the blood and lymph microvessels for evaluating anti-angiogenesis strategies in the therapy of prostate cancer is discussed.
Export Options
About this article
Cite this article as:
Coloma Almudena, Codesal Javier, Ingelmo Ildefonso, Ruiz Jesus, Teba Fernando, Pozuelo M. Jose, Rodriguez Rosario and Santamaria Luis, Stereological Quantification of Blood and Lymph Microvessels in Prostate Cancer. Its Relevance for the Anti-angiogenetic Therapy, Current Cancer Therapy Reviews 2014; 10 (1) . https://dx.doi.org/10.2174/157339471001140815151624
DOI https://dx.doi.org/10.2174/157339471001140815151624 |
Print ISSN 1573-3947 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6301 |
Call for Papers in Thematic Issues
Advancements in Lipid Nanoparticle Delivery Systems for mRNA Therapeutics
The thematic issue will focus on key areas such as lipid nanoparticles, mRNA therapeutics, drug delivery systems, nanotechnology in medicine, targeted therapy, non-viral vectors, precision medicine, and biomedical engineering.read more
Current progress in Protein Degradation and Cancer Therapy
argeted Protein Degradation is gaining momentum in cancer therapy, it facilitate targeting undruggable proteins, it overcome cancer resistance and avoid undesirable side effects. Thus small molecules degraders have emerged as novel therapeutic strategy. Targeted protein degradation (TPD), the process of eliminating a protein of interest hold a great promise for ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Human Kallikreins: Common Structural Features, Sequence Analysis and Evolution
Current Genomics Effects of Some Metal Ions on Human Erythrocyte Glutathione Reductase:An In Vitro Study
Protein & Peptide Letters Folate Based Radiopharmaceuticals for Imaging and Therapy of Cancer and Inflammation
Current Pharmaceutical Design Mitocans: Mitochondrial Targeted Anti-Cancer Drugs as Improved Therapies and Related Patent Documents
Recent Patents on Anti-Cancer Drug Discovery Pharmacologic Evidence of Green Tea in Targeting Tyrosine Kinases
Current Reviews in Clinical and Experimental Pharmacology Circulating Biochemical Markers of Brain Damage in Infants Complicated by Ischemia Reperfusion Injury
Cardiovascular & Hematological Agents in Medicinal Chemistry The Role of Physical Exercise and Omega-3 Fatty Acids in Depressive Illness in the Elderly
Current Neuropharmacology Update for Cancer Therapy with β-Lapachone
Medicinal Chemistry Reviews - Online (Discontinued) Molecular Mapping and Docking Interactions for Selective Anti-Fertility Potency of Estrogen Analogs
Letters in Drug Design & Discovery mRNA as a Versatile Tool for Exogenous Protein Expression
Current Gene Therapy Signaling Pathways Underpinning the Manifestations of Ionizing Radiation-Induced Bystander Effects
Current Molecular Pharmacology Multi-Kinase Inhibitors
Current Medicinal Chemistry Novel Patents Targeting Interleukin-17A; Implications in Cancer and Inflammation
Recent Patents on Anti-Cancer Drug Discovery Editorial Review 2017
Current Radiopharmaceuticals 5'-Nucleotidases, Nucleosides and their Distribution in the Brain: Pathological and Therapeutic Implications
Current Medicinal Chemistry A Review of the Three-Dimensional Cell Culture Technique: Approaches, Advantages and Applications
Current Stem Cell Research & Therapy Radiation Therapy in the Early 21st Century: Technological Advances
Current Cancer Therapy Reviews Small Molecular Inhibitors Targeting Chromatin Regulating Proteins for Cancer
Current Protein & Peptide Science Combined Treatment with JFKD and Gefitinib Overcomes Drug Resistance in Non-Small Cell Lung Cancer
Current Pharmaceutical Biotechnology Nerve Growth Factor: Early Studies and Recent Clinical Trials
Current Neuropharmacology